Overexpression of thioredoxin does not confer resistance to cisplatin in transfected human ovarian and colon cancer cell lines

Cancer Chemotherapy and Pharmacology

Volumn 40, Issue 1, 1997, Pages 31-37

  Yamada, Manabu ^a,b   Tomida, Akihiro ^a   Yoshikawa, Hiroyuki ^b   Taketani, Yuji ^b   Tsuruo, Takashi ^a,c  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c CANCER CHEMOTHERAPY CENTER   (Japan)

Author keywords

Cisplatin; Drug resistance; Oxidative stress; Thioredoxin; Transfection

Indexed keywords

CAMPTOTHECIN; CISPLATIN; DOXORUBICIN; HYDROGEN PEROXIDE; MITOMYCIN C; THIOREDOXIN;

ARTICLE; CELL LINE; COLON CANCER; CONTROLLED STUDY; DRUG RESISTANCE; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; OVARY CANCER; PRIORITY JOURNAL; TUMOR CELL;

ANTINEOPLASTIC AGENTS; CISPLATIN; COLONIC NEOPLASMS; DRUG RESISTANCE; FEMALE; HUMANS; HYDROGEN PEROXIDE; OVARIAN NEOPLASMS; REACTIVE OXYGEN SPECIES; THIOREDOXIN; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0030889295     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050621     Document Type: Article

References (34)

1. Abate C, Patel L, Rauscher FJ III, Curran T (1990) Redox regulation of fos and jun DNA-binding activity in vitro. Science 249: 1157
2. Buttke TM, Sandstrom PA (1994) Oxidative stress as a mediator of apoptosis. Immunol Today 15: 7
3. Chu G (1994) Cellular responses to cisplatin. The roles of DNA-binding proteins and DNA repair. J Biol Chem 269: 787
4. Fernando MR, Nanri H, Yoshitake S, Nagata-Kuno K, Minakami S (1992) Thioredoxin regenerates proteins inactivated by oxidative stress in endothelial cells. Eur J Biochem 209: 917
5. Fujii S, Nanbu Y, Nonogaki H, Konishi I, Mori T, Masutani H, Yodoi J (1991) Coexpression of adult T-cell leukemia-derived factor, a human thioredoxin homologue, and human papillomavirus DNA in neoplastic cervical squamous epithelium. Cancer 68: 1583
6. Hannemann J, Baumann K (1988) Cisplatin-induced lipid peroxidation and decrease of gluconeogenesis in rat kidney cortex: different effects of antioxidants and radical scavengers. Toxicology 51: 119
7. Hayashi T, Ueno Y, Okamoto T (1993) Oxidoreductive regulation of nuclear factor kappa B. Involvement of a cellular reducing catalyst thioredoxin. J Biol Chem 268: 11380
8. Holmgren A (1985) Thioredoxin. Annu Rev Biochem 54: 237
9. Holmeren A (1989) Thioredoxin and glutaredoxin systems. J Biol Chem 264: 13963
10. Hori K, Katayama M, Sato N, Ishii K, Waga S, Yodoi J (1994) Neuroprotection by glial cells through adult T cell leukemia-derived factor/human thioredoxin (ADF/TRX). Brain Res 652: 304
11. Izumi M, Miyazawa H, Kamakura T, Yamaguchi I, Endo T, Hanaoka F (1991) Blasticidin S-resistance gene (bsr): a novel selectable marker for mammalian cells. Exp Cell Res 197: 229
12. Kataoka S, Naito M, Tomida A, Tsuruo T (1994) Resistance to antitumor agent-induced apoptosis in a mutant of human myeloid leukemia U937 cells. Exp Cell Res 215: 199
13. Kitaoka Y, Sorachi K, Nakamura H, Masutani H, Mitsui A, Kobayashi F, Mori T, Yodoi J (1994) Detection of adult T-cell leukemia-derived factor human thioredoxin in human serum. Immunol Lett 41: 155
14. Lai G-M, Ozols RF, Young RC, Hamilton TC (1989) Effect of glutathione on DNA repair in cisplatin-resistant human ovarian cancer cell lines. J Natl Cancer Inst 81: 535
15. Larrick JW, Wright SC (1990) Cytotoxic mechanism of tumor necrosis factor-α. FASEB J 4: 3215
16. Lee J-H, Naito M, Tsuruo T (1994) Nonenzymatic reductive activation of 7-N-{{2-{[2-(γ-L-glutamino)ethyl]dithio}ethyl} mitomycin C by thiol molecules: a novel mitomycin C derivative effective on mitomycin C-resistant tumor cells. Cancer Res 54: 2398
17. Masuda H, Tanaka T, Takahama U (1994) Cisplatin generates Superoxide anion by interaction with DNA in a cell-free system. Biochem Biophys Res Commun 203: 1175
18. Matsuda M, Masutani H, Nakamura H, Miyajima S, Yamauchi A, Yonehara S, Uchida A, Irimajiri K, Horiuchi A, Yodoi J (1991) Protective activity of adult T cell leukemia-derived factor (ADF) against tumor necrosis factor-dependent cytotoxicity on U937 cells. J Immunol 147: 3837
19. Mayer M, Noble M (1994) N-acetyl-L-cysteine is a pluripotent protector against cell death and enhancer of trophic factor-mediated cell survival in vitro. Proc Natl Acad Sci USA 91: 7496
20. Mitsui A, Hirakawa T, Yodoi J (1992) Reactive oxygen-reducing and protein-refolding activities of adult T cell leukemia-derived factor/human thioredoxin. Biochem Biophys Res Commun 186: 1220
21. Mizumoto K, Rothman RJ, Farber JL (1994) Programmed cell death (apoptosis) of mouse fibroblasts is induced by the topoisomerase II inhibitor etoposide. Mol Pharmacol 46: 890
22. Nakamura H, Matsuda M, Furuke K, Kitaoka Y, Iwata S, Toda K, Inamoto T, Yamaoka Y, Ozawa K, Yodoi J (1994) Adult T cell leukemia-derived factor/human thioredoxin protects endothelial F-2 cell injury caused by activated neutrophils or hydrogen peroxide. Immunol Lett 42: 75
23. Ohira A, Honda O, Gauntt CD, Yamamoto M, Hori K, Masutani H, Yodoi J, Honda Y (1994) Oxidative stress induces adult T cell leukemia derived factor/thioredoxin in the rat retina. Lab Invest 70: 279
24. Peppel K, Baglioni C (1990) A simple and fast method to extract RNA from tissue culture cells. Biotechniques 9: 711
25. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning. a laboratory manual. Cold Spring Harbor Laboratory Press
26. Sasada T, Iwata S, Sato N, Kitaoka Y, Hirota K, Nakamura K, Nishiyama A, Taniguchi Y, Takabayashi A, Yodoi J (1996) Redox control of resistance to cis-diaminedichloroplatinum (II) (CDDP). Protective effect of human thioredoxin against CDDP-induced cytotoxicity. J Clin Invest 97: 2268
27. Schenk H, Klein M, Erdbrügger W, Dröge W, Schulze-Osthoff K (1994) Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-κB and AP-1. Proc Natl Acad Sci USA 91: 1672
28. Sugihara K, Gemba M (1986) Modification of cisplatin toxicity by antioxidants. Jpn J Pharmacol 40: 353
29. Tagaya Y, Maeda Y, Mitsui A, Kondo N, Matsui H, Hamuro J, Brown N, Arai K, Yokota T, Wakasugi H, Yodoi J (1989) ATL-derived factor (ADF), an IL-2 receptor Tac inducer homologous to thioredoxin; possible involvement of dithiol-reduction in the IL-2 receptor induction. EMBO J 8: 757
30. Tomida A, Naito M, Tsuruo T (1995) Acute induction of adriamycin-resistance in human colon carcinoma HT-29 cells exposed to a sublethal dose of adriamycin. Jpn J Cancer Res 86: 224
31. Tomimoto H, Akiguchi I, Wakita H, Kimura J, Hori K, Yodoi J (1993) Astroglial expression of ATL-derived factor, a human thioredoxin homologue, in the gerbil brain after transient global ischemia. Brain Res 625: 1
32. Woolley PV III, Kumar S, Monks TJ, Ortiz JE (1988) Colon cancer as a model for resistance to antineoplastic drugs. In: Wooley PV III. Tew KD (eds) Mechanisms of drug resistance in neoplastic cells. Academic Press, San Diego, p 3
33. Yamada M, Tomida A, Yoshikawa H, Taketani Y, Tsuruo T (1996) Increased expression of thioredoxin adult T-cell leukemia-derived factor in cisplatin-resistant human cancer cell lines. Clin Cancer Res 2: 427
34. Yokomizo A, Ono M, Nanri H, Makino Y, Ohga T, Wada M, Okamoto T, Yodoi J, Kuwano M, Kohno K (1995) Cellular levels of thioredoxin associated with drug sensitivity to cisplatin, mitomycin C, doxorubicin, and etoposide. Cancer Res 55: 4293